Skip to main content

Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids

  • Conference paper
Nuclear Medicine in Clinical Oncology
  • 77 Accesses

Abstract

The concept of treating effusions due to pleura or peritoneal carcinosis with radioactive colloids was introduced 40 years ago [2]. For this purpose, 63Zn sulfide and later on 198Au colloid have been used [2, 3]. Both cases involved the application of beta and gamma emitters, where the beta emission was almost exclusively responsible for the therapeutic effect. As the gamma radiation necessitated inconvenient precautions for radiation protection [1], radioactive colloids with pure beta emission have been developed since 1954 for intracavitary radionuclide therapy [4–7]. This concerned primarily 32P chromium phosphate and 90Y silicate; 169Er citrate and 186Re sulfate were also recommended. Whereas the two latter compounds were not applied on a large scale, the 90Y colloid has for almost 30 years proved to be the most suitable substance for the treatment of malignant effusions in pleura and peritoneum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Becker J, Scheer KE (1961) Die lokalisierte Applikation künstlich radioaktiver Isotope. In: Höfer K (ed) Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie, vol 2. Springer, Berlin Göttingen Heidelberg, p 702

    Google Scholar 

  2. Müller JH (1945) Über die Verwendung von künstlich radioaktiven Isotopen zur Erzielung von lokalisierten biologischen Strahlenwirkungen. Experientia 1:199

    Article  Google Scholar 

  3. Müller JH (1961) Interne Tumortherapie mit künstlich radioaktiven Isotopen. In: Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie, vol 2. Springer, Berlin Göttingen Heidelberg, p 785

    Google Scholar 

  4. Riccabona G (1978) Intracavitäre Isotopentherapie, klinische Bedeutung in Diagnostik und Therapie. Nuc Med, p 698

    Google Scholar 

  5. Riccabona G (1983) Therapy with radionuclides — Actual state of the art. In: Nuclearmedi-cine, imaging of metabolism and organ function. Schattauer, Stuttgart, p 910

    Google Scholar 

  6. Root SW, Taylor MP, Andrews GA, Knisely RM (1954) Distribution of colloidal radioactive chromic phosphate after intracavitary administration. Radiology 63:251

    PubMed  CAS  Google Scholar 

  7. Siegel EP, Hart HE, Brothers M, Spencer H, Laszlo D (1956) Radio-yttrium (90Y) for the palliative treatment of effusions due to malignancy. JAMA 161:499

    CAS  Google Scholar 

  8. Weisberger AS, Levine B, Storaasli JP (1955) Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA 159:1704

    CAS  Google Scholar 

  9. Zaloznik AJ, Oswald SG, Langin M (1983) Intrapleural tetracycline in malignant pleural effusions, a randomized study. Cancer 51:752–755

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Riccabona, G. (1986). Treatment of Pleural and Peritoneal Carcinosis with Radioactive Colloids. In: Winkler, C. (eds) Nuclear Medicine in Clinical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70947-0_52

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70947-0_52

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16164-6

  • Online ISBN: 978-3-642-70947-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics